Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders
- 3 December 2002
- journal article
- Published by Springer Science and Business Media LLC in European Journal of Human Genetics
- Vol. 10 (12), 819-824
- https://doi.org/10.1038/sj.ejhg.5200883
Abstract
The European Journal of Human Genetics is the official Journal of the European Society of Human Genetics, publishing high-quality, original research papers, short reports, News and Commentary articles and reviews in the rapidly expanding field of human genetics and genomics.Keywords
This publication has 25 references indexed in Scilit:
- Distinct Missense Mutations of the FGFR3 Lys650 Codon Modulate Receptor Kinase Activation and the Severity of the Skeletal Dysplasia PhenotypeAmerican Journal of Human Genetics, 2000
- RTK mutations and human syndromesTrends in Genetics, 2000
- The Molecular and Genetic Basis of Fibroblast Growth Factor Receptor 3 Disorders: The Achondroplasia Family of Skeletal Dysplasias, Muenke Craniosynostosis, and Crouzon Syndrome with Acanthosis Nigricans*Endocrine Reviews, 2000
- Frequent activating mutations of FGFR3 in human bladder and cervix carcinomasNature Genetics, 1999
- Clinical spectrum of fibroblast growth factor receptor mutationsHuman Mutation, 1999
- Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossificationMechanisms of Development, 1998
- Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3Nature Genetics, 1997
- FGFR activation in skeletal disorders: Too much of a good thingTrends in Genetics, 1997
- Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasiaNature Genetics, 1996
- Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3Nature Genetics, 1995